This question tests recognition and management of IV therapy complications, specifically immediate intervention for infiltration during medication administration. The priority concern is halting further fluid leakage to prevent tissue damage. The correct answer, cool swelling at the IV site with slowed infusion, is the best choice for client safety as it necessitates stopping the IV promptly. Nausea, lifting dressing edges, or mild soreness are less urgent and not indicative of infiltration. A key clinical judgment principle is to integrate client reports with physical assessments. Another principle is to differentiate medication side effects from IV complications. A transferable strategy is to monitor infusion rates and site integrity during drug administration to manage IV sites effectively.

This question tests recognition and management of IV therapy complications, specifically unsafe orders that could worsen infiltration. The priority concern is preventing continued infusion through a potentially infiltrated site that could cause tissue damage. The instruction to continue the infusion if the IV site is painful (Option A) should be questioned because pain, along with the noted swelling and coolness, indicates possible infiltration that requires stopping the infusion and site evaluation. Options B, C, and D represent appropriate aspects of the order: 50 mL is a reasonable IVPB volume, peripheral IV use is acceptable for furosemide, and 10 minutes is an appropriate infusion time. The clinical judgment principle is that pain at an IV site, especially with other signs of infiltration, warrants immediate assessment and likely discontinuation rather than continuation. A transferable strategy for safe IV therapy is to question any order that directs continuation of infusion despite signs or symptoms of complications.

This question tests recognition and management of IV therapy complications, specifically infiltration during antibiotic therapy. The priority concern is distinguishing from infection to ensure appropriate intervention. The correct answer, edema and coolness at the site with decreased infusion flow, is the best choice for client safety as it signals infiltration. Warmth with cord suggests phlebitis; elevated temperature indicates systemic infection; bright blood in tubing is normal, all less optimal or incorrect. A key clinical judgment principle is to evaluate flow rates as patency clues. Another principle is to inspect dressings for integrity. A transferable strategy is to document baseline and ongoing assessments to manage IV sites effectively.

This question tests recognition and management of IV therapy complications, specifically the priority response to suspected extravasation. The priority concern is preventing severe tissue damage from vesicant or irritating medications leaking into surrounding tissues. Stopping the infusion and leaving the IV catheter in place (Option A) is the correct priority action because it prevents further medication from entering tissues while maintaining access for potential antidote administration per facility protocol. Option B (slowing the rate) would continue tissue damage, Option C (warm compress) could worsen chemical injury and continuing infusion is dangerous, and Option D (immediate removal) eliminates the route for antidote administration if indicated. The clinical judgment principle is that extravasation of vesicants requires immediate cessation of infusion while preserving the catheter for potential antidote delivery. A transferable strategy for managing suspected extravasation is to follow the acronym STOP: Stop infusion, Take aspirate if possible, Observe and document, and Proceed with facility protocol including possible antidote administration.

This question tests recognition and management of IV therapy complications with antibiotic administration. The priority concern is preventing tissue damage from infiltrated fluid and ensuring effective antibiotic delivery. Stopping the infusion, removing the IV catheter, elevating the extremity, and restarting IV access in a new site (Option A) is the correct action for managing infiltration, as it prevents further fluid accumulation, promotes drainage, and ensures reliable vascular access for medication delivery. Option B (continuing infusion) would worsen tissue damage, Option C (massaging) could spread fluid and is not evidence-based, and Option D (obtaining provider order) unnecessarily delays intervention for a nursing-driven protocol. The clinical judgment principle is that infiltration management is within nursing scope of practice and requires prompt intervention to prevent complications. A transferable strategy for managing infiltration is to follow the sequence: stop infusion, remove catheter, elevate extremity, apply appropriate compress per protocol, document thoroughly, and establish new access as needed.

This question tests recognition and management of IV therapy complications in elderly patients receiving continuous fluids. The priority concern is identifying infiltration that requires immediate intervention to prevent tissue damage and fluid overload complications. Cool, blanched skin with increasing edema and pump high-pressure alarms (Option A) clearly indicates infiltration requiring immediate action, as these signs show fluid accumulating in tissues with vascular compression. Option B (mild nausea) is unrelated to IV complications, Option C (normal respiratory status) shows no signs of fluid overload, and Option D (slight BP variation) is not clinically significant. The clinical judgment principle is that elderly patients are at higher risk for infiltration due to fragile veins, and continuous monitoring is essential to detect complications early. A transferable strategy for preventing infiltration in high-risk patients is to use appropriate catheter gauge for vein size, rotate sites per protocol, and perform hourly assessments with documentation using standardized infiltration scales.

This question tests recognition and management of IV therapy complications, specifically extravasation of vesicant chemotherapy in pediatric patients. The priority concern is preventing severe tissue necrosis from vesicant medications leaking into surrounding tissues. Stopping the infusion and maintaining the catheter for possible antidote administration (Option A) is the correct priority action, as many chemotherapy agents have specific antidotes that must be administered through the same catheter. Option B (flushing vigorously) would push more vesicant into tissues, Option C (continuing infusion) would worsen tissue damage, and Option D (applying pressure) is inappropriate and delays critical intervention. The clinical judgment principle is that vesicant extravasation is a medical emergency requiring immediate cessation of infusion while preserving access for antidote delivery according to facility protocols. A transferable strategy for preventing chemotherapy extravasation is to verify blood return before, during, and after vesicant administration, and to use central venous access when possible for these high-risk medications.

This question tests recognition and management of IV therapy complications, specifically identifying signs of infiltration. The priority concern is recognizing infiltration early to prevent tissue damage from fluid accumulation in surrounding tissues. Cool, pale skin with swelling and a slowed infusion rate (Option B) correctly identifies the classic triad of infiltration: coolness from non-warmed fluid in tissues, pallor from compressed capillaries, and swelling from fluid accumulation outside the vein. Option A describes phlebitis (vein inflammation), Option C indicates a patent IV with no complications, and Option D suggests systemic infection rather than a local complication. The clinical judgment principle is that infiltration presents with local signs of fluid in tissues (cool, swollen, slow flow) rather than inflammatory signs. A transferable strategy is to assess IV sites systematically using the mnemonic REEDA: Redness, Edema, Ecchymosis, Drainage, and Approximation, while also checking temperature and flow rate.

This question tests recognition and management of IV therapy complications, specifically immediate intervention for infiltration in a vulnerable client. The priority concern is protecting circulation in peripheral vascular disease. The correct answer, cool, pale, swollen IV site with sluggish infusion, is the best choice for client safety as it demands prompt action. Requests for water, elevated BP, or small ecchymosis are less urgent. A key clinical judgment principle is to prioritize site assessments in high-risk clients. Another principle is to correlate sluggish flow with physical findings. A transferable strategy is to choose distal sites carefully and monitor perfusion to manage IV sites effectively.

This question tests recognition and management of IV therapy complications, specifically immediate intervention for infiltration during antibiotic infusion. The priority concern is preventing further discomfort and tissue damage. The correct answer, new swelling and coolness at the IV site with pain on flushing, is the best choice for client safety as it requires IV discontinuation. Infusion delay, metallic taste, or tape redness are less urgent. A key clinical judgment principle is to assess for infiltration with irritant drugs like vancomycin. Another principle is to avoid confusing side effects with site complications. A transferable strategy is to flush and observe for pain before and after doses to manage IV sites effectively.